Insulin aspart, recombinant Subcutaneous and Relistor (Methylnaltrexone Tablets)
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Relistor (Methylnaltrexone Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: methylnaltrexone
Brand name: Relistor
Synonyms: Relistor
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Relistor Oral
- Insulin aspart, recombinant Subcutaneous-Relistor Tablets
- Insulin aspart, recombinant Subcutaneous-Relnate DHA
- Insulin aspart, recombinant Subcutaneous-Relpax
- Insulin aspart, recombinant Subcutaneous-Relyyks
- Insulin aspart, recombinant Subcutaneous-Relyyks Patch
- Relistor (Methylnaltrexone Tablets)-Insulin degludec
- Relistor (Methylnaltrexone Tablets)-Insulin Degludec (U-100) Prefilled Pens
- Relistor (Methylnaltrexone Tablets)-Insulin Degludec (U-100) Vials
- Relistor (Methylnaltrexone Tablets)-Insulin Degludec (U-200) Prefilled Pens
- Relistor (Methylnaltrexone Tablets)-Insulin degludec and liraglutide
- Relistor (Methylnaltrexone Tablets)-Insulin degludec and liraglutide Subcutaneous